Shiba Inu: GM1 gangliosidosis and why to insist on DNA-tested parents
Published by Planète Pets · managing editor: Clément Lacaille · how our guides are written
On the list of Shiba Inu conditions, GM1 gangliosidosis sits apart: it is rare, it is fatal, and it is entirely avoidable. Our piece on Shiba Inu health, eyes and skin mentions it among others; this one explains what the screening data show and how to use them with a breeder.
Contents · 6 sections
What the disease does
It is a lysosomal storage disease: a deficiency of acid beta-galactosidase, caused by the GLB1 c.1649delC mutation, prevents the breakdown of gangliosides, which accumulate in neurons. The puppy is born normal and develops normally, then around five to six months starts losing balance, stands with legs splayed, shows head tremors and a high-stepping gait, then declining vision. The course is relentless and death usually occurs around twelve to fifteen months. There is no treatment.
A rare disease, concentrated in certain lines
The study by M. M. Uddin, S. Arata, Y. Takeuchi, O. Yamato and colleagues, published in 2013 in BMC Veterinary Research, genotyped 590 clinically healthy Shibas across eight Japanese districts: 1.02% carriers on average, but 2.27% in the Kinki district (see the study). Of the 23 affected dogs recorded over sixteen years, 52.2% came from that same district, and pedigree analysis shows that all documented affected dogs and carriers are closely related. That is the classic signature of a mutation circulating within a small number of lines: the risk is not spread evenly across the breed, it depends entirely on a puppy's ancestry.
The Mame Shiba case
The miniature Shiba, or Mame Shiba, much in demand, comes from an even narrower gene pool. The survey by S. Pervin, M. S. Islam, A. Yabuki, O. Yamato and colleagues, published in 2022 in the journal Animals, tested 1,832 adult Mame Shiba breeding dogs across 143 Japanese kennels: 0.49% carriers, for a mutant allele frequency of 0.00246 (see the study). The authors consider that frequency high enough to justify control measures. A carrier rate under 1% may sound reassuring: it is not, in a breed where related lines are frequently crossed.
What exactly to ask for
Inheritance is recessive: two healthy carriers bred together produce statistically 25% affected puppies. So ask for the GM1 DNA test result for both parents, with the laboratory name and date — not a general health certificate. One clear parent guarantees no puppy will be affected, but not that none will be a carrier: if you plan to breed your dog later, have it tested too. The question is especially relevant for a puppy imported from Japan or from recent Japanese lines. The breed's full profile is on its profile page, and other follow-up points are in our dog care and grooming section.
The financial side
A DNA test costs a few tens of euros; the diagnostic wandering of an ataxic puppy, with MRI and cerebrospinal fluid analysis, costs several hundred with no possible outcome. And inherited disease is among the commonest policy exclusions: see insuring a Shiba Inu.
Frequently asked questions
Is a carrier dog ill?
No. A heterozygous carrier is clinically normal for life. It only matters if bred to another carrier.
Can an adult dog already adopted be tested?
Yes, a simple cheek swab is enough. It is essential before any mating, pointless in a neutered, healthy dog.
Does the disease exist outside Japan?
Yes, wherever Japanese lines circulate. The most solid prevalence data remain Japanese, for lack of equivalent surveys elsewhere.
An accessory from our shop for this use: Soft inflatable recovery collar for dogs (€29.90) · the whole shop
This guide is part of Planète Pets’s Dogs universe. Our advice is general in nature: for any health concern, your veterinarian remains the only reference.